Researchers in the lab of Dr. Hugh D.C. Smyth have released promising results of a new method to treat SARS-CoV-2, the coronavirus that causes COVID-19. The antiviral niclosamide, when incorporated with human lysozyme as a carrier molecule, shows potential as an effective COVID-19 treatment when delivered directly to the airways.
An update from Dean M. Lynn Crismon regarding the College of Pharmacy’s transition to remote learning and efforts to learn, research, graduate, and stay healthy during the COVID-19 pandemic.